FDA's Specialized Inspectorate Means Industry Must Boost Readiness
This article was originally published in The Pink Sheet Daily
Executive Summary
Firms may experience smoother facility visits after FDA reorganizes, but inspections will not necessarily result in fewer deficiencies, attorneys argue.